(Q35680309)

9 August 2017

1 reference

title

Breast cancer biomarkers and molecular medicine: part II. (English)

1 reference

9 August 2017

0 references

8

Gabriel N Hortobagyi

1 reference

9 August 2017

Jeffrey S Ross

1

1 reference

9 August 2017

Gerald P Linette

2

1 reference

9 August 2017

James Stec

3

1 reference

9 August 2017

Edwin Clark

4

1 reference

9 August 2017

Mark Ayers

5

1 reference

9 August 2017

Nick Leschly

6

1 reference

9 August 2017

W Fraser Symmans

7

1 reference

9 August 2017

Lajos Pusztai

9

1 reference

9 August 2017

publication date

1 March 2004

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

9 August 2017

published in

1 reference

9 August 2017

volume

4

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

169-188

1 reference

Breast cancer biomarkers and molecular medicine

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Prognostic significance of circulating P53 antibodies in patients undergoing surgery for locoregional breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Assessment of molecular markers of clinical sensitivity to single-agent taxane therapy for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

The retinoblastoma gene: its role in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Nm23 gene product expression in invasive breast cancer--immunohistochemical analysis and clinicopathological correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Negative regulators of cyclin-dependent kinases and their roles in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

The INK4a/ARF network in tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Expression of maspin predicts poor prognosis in breast-cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Maspin expression in invasive breast cancer: association with other prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

E-cadherin as a prognostic indicator in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Adhesion receptors and cell invasion: mechanisms of integrin-guided degradation of extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Prognostic significance of micrometastatic bone marrow involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Clinical experience with edrecolomab: a monoclonal antibody therapy for colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Matrix metalloproteinases: a tail of a frog that became a prince

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Matrix metalloproteinases: multifunctional contributors to tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Steroid hormone receptors in breast cancer management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

The value of estrogen and progesterone receptor determinations in advanced breast cancer. Estrogen receptor level but not progesterone receptor level correlates with response to tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

The role of the estrogen receptor in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Molecular markers for predicting response to tamoxifen in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

The evolving role of specific estrogen receptor modulators (SERMs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Anti-tumor effects of letrozole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Expression of MDR1 and glutatione S transferase-π genes and chemosensitivities in human gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Heat shock proteins and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Studies of apoptosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Number of apoptotic cells as a prognostic marker in invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

The NF-kappa B and I kappa B proteins: new discoveries and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

NF-kappaB in cancer: from innocent bystander to major culprit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Telomerase and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Telomerase activity and prognosis in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

DNA instability and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

DNA methylation and breast carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

DNA methylation in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Nuclear matrix proteins as biomarkers for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Predicting the clinical status of human breast cancer by using gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Using genetic variation to study human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

Update on pharmacogenetics in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.2.169

21 January 2018

Identifiers

DOI

10.1586/14737159.4.2.169

1 reference

release_a6u3bph5hjg4nfuzg2pjxbnnx4

9 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/a6u3bph5hjg4nfuzg2pjxbnnx4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference